J&J can produce up to 900 million coronavirus vaccine doses by April 2021 if trials go well – CNBC

1. J&J can produce up to 900 million coronavirus vaccine doses by April 2021 if trials go well  CNBC
2. Johnson & Johnson’s stock surges after earnings beat, raised dividend  MarketWatch
3. J&J beats profit estimates but coronavirus fuels forecast cut  Yahoo Finance
4. J&J raises dividend but cuts 2020 earnings outlook over coronavirus outbreak; shares rise  CNBC
5. JNJ Stock Rises After Medical Giant Tops First-Quarter Estimates  Investor’s Business Daily
6. View Full Coverage on Google News

Source: Air Tools